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Background: There have been very few observational studies of drug and alcohol misuse in 
ﬁ  rst-episode psychosis in the UK.
Method: Using an observational database of ﬁ  rst episode psychosis in Northumberland, a 
county in Northern England, information on patients aged 16 to 36 years were collected at 
presentation and annual follow-up between October 1998 and October 2005. Patterns of drug 
and alcohol misuse were compared using hospitalization as an outcome measure, and violence 
rates were examined retrospectively.
Results: Drug misuse without alcohol misuse was associated with a highly signiﬁ  cant increase 
in hospital days. An alcohol problem, either with or without coexisting drug misuse, was not 
predictive of increased hospital days. Drug and alcohol misuse together was associated with 
violence.
Conclusions: This paper lends some support to those Early Intervention in Psychosis (EIP) 
teams currently advising patients that drug misuse may have a greater impact than alcohol use 
on the outcome of ﬁ  rst-episode psychosis.
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Introduction
Comorbid substance misuse and psychosis have been shown to be associated with 
longer in-patient stays (Menezes et al 1996), increased symptom severity (Drake and 
Wallach 1989; Drake et al 1989), greater noncompliance with treatment (Bebbington 
1995; Olfson et al 2000), higher rates of homelessness (Drake et al 1991) and increased 
aggression (Soyka 2000). A study by Barnett and colleagues (2007) found substance 
misuse in people with ﬁ  rst episode psychosis to be twice that of the general popula-
tion. Despite these associations, there is a paucity of evidence on the epidemiology of 
comorbid illegal drug misuse and alcohol misuse in ﬁ  rst-episode psychosis.
Most research into the role of substance misuse in psychosis has focused on can-
nabis and amphetamines, and very little has been published in recent years on the role 
of alcohol misuse in psychosis. Although there seems little doubt that cannabis plays an 
important role in the development of schizophrenia, the relationship between alcohol and 
psychosis remains unclear. There is general agreement within the literature that aside 
from nicotine, alcohol and cannabis are the substances most commonly used by people 
with psychotic disorders (Margolese et al 2004). In a general adult population survey 
in Great Britain, alcohol dependence was predictive of psychotic experience (Johns 
et al 2004). The reported two-fold higher risk was independent of other risk factors for 
psychotic symptoms including drug dependence, suggesting that alcohol dependence 
per se doubles the risk of developing psychotic symptoms. There is also much evidence 
that substance misuse acts as a perpetuating factor for psychotic symptoms and, in fact, 
a reduction in substance misuse after diagnosis has been associated with a reduction in 
psychotic symptoms and hospital admissions (Lambert et al 2005).Neuropsychiatric Disease and Treatment 2008:4(2) 418
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Most previous studies have used samples that included 
patients with varying durations of illness (Duke et al 1994; 
Menezes et al 1996; Graham et al 2001; McCreadie 2002; 
Weaver et al 2003; Wright et al 2000; Cantwell 2003). In 
fact, only 3 UK studies were found that focused on drug 
and alcohol misuse in ﬁ  rst-episode psychosis (Cantwell 
et al 1999; Barnes et al 2006; Barnett et al 2007). In 1993, 
Cantwell pointed out that studies that focused on ﬁ  rst-episode 
psychosis were almost exclusively North American, and this 
has not changed.
Most UK studies on ﬁ  rst-episode psychosis published to 
date have concentrated on inner-city samples, particularly 
London (Duke et al 1994; Menezes et al 1996; Barnes et al 
2006). Only two UK studies (McCreadie 2002; Cantwell 
2003) and one US study included patients from urban and 
rural settings.
The UK government has invested heavily over the past 
decade in developing Early Intervention in Psychosis (EIP) 
teams as an integral part of standard mental health services 
across the country (Pelosi and Birchwood 2003). The aim 
of EIP teams is, in line with British Health Policy, to pro-
vide quick and effective treatment to patients aged under 
36 years with the rationale that early treatment of psychotic 
symptoms leads to a higher success rate. The objectives of 
the study were to examine the effects of drug and alcohol 
misuse in a sample of 251 people aged under 36 years who 
presented with a ﬁ  rst episode psychosis between October 
1998 and October 2005 drawn from rural and urban settings 
in a geographically deﬁ  ned region in the north of England. 
Prospective data on hospital admissions and retrospective 
data on rates of violence in the substance misuse groups 
were analyzed.
Method
Background
The PACE (population-adjusted clinical epidemiology) 
process was developed and reﬁ  ned over a 15 year period in 
hematological malignancy (Charlton et al 1997; Proctor and 
Taylor 2000; Proctor 2002). In 1998 the methodology was 
adapted for use in mental health. PACE is an observational 
database used to record prospective data on the presentation, 
management, and outcomes of all patients aged 16 years and 
over with a ﬁ  rst-episode psychosis referred to secondary 
care mental health services in a Northumberland, a county 
in northern England. It was developed for the purposes of 
service evaluation and audit, with the aim of improving ser-
vices (Proctor et al 2004). For example, a recent PACE study 
(Crebbin et al 2007) found a surprisingly high incidence of 
psychotic depression that will lead the Trust to review its 
policies and procedures for this patient group.
Participants
Data on patients aged between 16 and 36 years (at the time 
of ﬁ  rst presentation) seen by adult consultant psychiatrists 
in Northumberland between 1st October 1998 and 30th 
September 2005 with a ﬁ  rst episode psychotic illness, accord-
ing to ICD-10 criteria, were included. The ICD-10 diagnosis 
deﬁ  nitions used in this study are shown in Table 1. The only 
exclusion criteria were: presentation outside of the Trust area 
with a ﬁ  rst-episode psychosis and a past history of treated 
Table 1 ICD10 diagnoses and deﬁ  nitions used for PACE
ICD10 code  Diagnosis  No. of patients 
   under 36 years 
   (n = 251)
F6.2  Organic delusional (schizophrenia-like) disorder  4
F10–19.5  Mental and behavioral disorders due to use of psychoactive   35(2 with F10.5)
  substance use with psychotic symptoms
F20 Schizophrenia  42
F21 Schizotypal  disorder  0
F22  Persistent delusional disorders  5
F23  Acute and transient psychotic disorders  62
F25 Schizoaffective  disorders  7
F28  Other nonorganic psychotic disorders  45
F29 Unspeciﬁ  ed nonorganic psychosis  2
F30.2  Manic episode with psychotic symptoms  5
F31.2  Bipolar affective disorder with psychotic symptoms  13
F32.3  Severe depressive episode with psychotic symptoms  31
F20–29  Schizophrenia, schizotypal, and delusional disorders  163
F30–33 Mood  (affective)  disorders  49Neuropsychiatric Disease and Treatment 2008:4(2) 419
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psychosis. Information on patients’ drug and alcohol misuse 
patterns were collected from secondary care medical notes 
at the time of presentation to secondary care services. This 
data relied on clinician judgment and patients’ self-reports. 
Patients were subsequently divided into four groups:
1.  Illegal drug misuse. This included patients who were 
currently using any illegal drugs regardless of amount 
or frequency.
2.  Alcohol misuse. This included patients reported in case 
notes to have an alcohol problem at the time of presenta-
tion, or who consumed above the Government’s recom-
mended weekly limits.
3.  Both drug and alcohol misuse. This included patients 
who were reported as using illegal drugs and having an 
alcohol problem.
4.  Neither drug or alcohol misuse. These patients were not 
reported as using illegal drugs or misusing alcohol.
Procedure
Patient records for all patients with a ﬁ  rst episode psychosis 
presenting to the Trust between 1st October 1998 and 30th 
September 2005 were examined by PACE staff and relevant 
data were extracted. Information regarding demographics, 
drug misuse, alcohol misuse, hospital admissions, and risk 
of violence were collected from inpatient and outpatient 
secondary care medical notes and the data were entered 
onto an Access database. Patients’ secondary care medical 
notes were searched annually on the anniversary of their 
presentation. Monthly reminders were sent to all consultant 
psychiatrists, asking for names of patients who had recently 
presented with a ﬁ  rst-episode psychosis, both inpatients 
and outpatients. PACE staff also screened the computerized 
patient information system for potential patients who had 
been discharged from hospital.
Analysis
On the basis of outcome data participants were categorized 
into one of the four substance misuse groups and the data 
were analyzed using SPSS 14.0 for Windows. Continuous 
data were analysed using either an analysis of variance test 
or independent samples t-test, and the ordinal data using 
the chi-square test. Differences signiﬁ  cant at least at the 5% 
level were reported.
Conﬁ  dentiality
Conﬁ  dentiality was strictly maintained. After data collection, 
patient identiﬁ  able data were stored on a secure database, 
and in a locked cabinet, which only PACE staff were able 
to access. For the purposes of analysis, patients were given 
unique PACE identiﬁ  cation numbers and data were always 
presented in the form of group outcomes. PACE staff had 
no contact with patients, and were not involved in their 
care or management. The database was set up with the aim 
of service evaluation as deﬁ  ned by the National Research 
Ethics Service (see www.nres.npsa.nhs.uk), therefore, did 
not require ethical approval.
Results
Characteristics of the sample
251 patients aged under 36 years presented between October 
1998 and October 2005 with a ﬁ  rst episode psychosis, diag-
nosed according to ICD-10 criteria. There were 176 males 
and 75 females with a mean age of 25.1 years [standard devia-
tion (SD) 5.6 years]. The ages ranged from 16 to 35 years.
At presentation, 140 (55.8%) currently used illicit drugs 
(with or without alcohol) and 88 (35.1%) currently misused 
alcohol (with or without drugs). For comparison, this sample 
was divided into 4 groups:
1.  Illicit drug misuse (n = 77; mean age 23.3 years; 
SD 5.4 years). This group included 60 males and 17 
females [Risk ratio (RR) = 0.567; Conﬁ  dence interval 
(CI) = 0.304, 1.058].
2. Alcohol  misuse  (n  = 25; mean age 25.6 years; SD 5.9 
years). This group included 16 males and 9 females 
(RR = 1.364; CI = 0.574, 3.24).
3.  Both illicit drug misuse and alcohol misuse (n = 63; mean 
age 24.4 years; SD 5.4 years). This group included 55 
males and 8 females (RR = 0.263; CI = 0.118, 0.584).
4.  No illicit drug misuse or alcohol misuse (n = 86; mean 
age 27.0 years; SD 5.4 years). This group included 45 
males and 41 females (RR = 3.510; CI = 1.991, 6.188).
Hospital admissions
All diagnoses (n = 251)
A one-way between groups analysis of variance (ANOVA) 
was conducted to explore differences in hospital days 
between the groups. Table 2 shows hospital admission data 
for the groups. There was a statistically signiﬁ  cant difference 
at the p  0.01 level between the four groups for hospital 
days [F (3, 247) = 4.8, p = 0.003]. Post-hoc comparisons 
using the Tukey HSD test indicated that patients who misused 
drugs had signiﬁ  cantly more hospital days than those who: 
misused alcohol [mean of 210 days (SD 393) compared with 
36 days (SD 87); p = 0.02], misused both drugs and alcohol 
[mean of 76 days (SD 171); p = 0.02], and did not misuse 
drugs or alcohol [mean of 95 days (SD 193); p  0.03]. No Neuropsychiatric Disease and Treatment 2008:4(2) 420
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signiﬁ  cant differences were found between patients who 
misused alcohol and those who did not misuse any substances 
(p = 0.97).
The covariate effect of the substance misuse groups 
on the total number of hospital days was signiﬁ  cant at 
F(1,248) = 7.48, p = 0.007.
Violence towards others and property
All diagnoses (n = 251)
A chi-square test was conducted to explore differences 
between the groups regarding physical violence towards 
others and violence towards property measured at the time of 
ﬁ  rst presentation to services. Table 2 shows rates of violence 
for the groups. Patients who misused both drugs and alcohol 
were more likely (p  0.001) to have been physically violent 
towards others prior to presentation (n = 29; 46%) than those 
who: misused drugs (n = 22; 29%), misused alcohol (n = 5; 
20%), and did not misuse substances (n = 7; 8%).
Patients who misused both drugs and alcohol were also 
more likely (p  0.001) to have harmed property (n = 22; 
35%) than those who misused drugs (n = 19; 25%), mis-
used alcohol (n = 2; 8%), and did not misuse substances 
(n = 4; 5%).
Of the 251 patients, only 159 (63%) were still in contact 
with secondary care mental health services after 1 year. Of 
those, 46 (29%) still had a documented alcohol problem, 44 
(28%) were still misusing drugs and 19 (12%) had a drug 
and alcohol problem. Over the previous year, 19 (12%) had 
physically harmed others. We will be investigating this further. 
There is no information available on what has happened to 
those who are no longer in contact with psychiatric services.
Discussion
Prevalence and characteristics of the sample
In line with previous ﬁ  ndings, drug and alcohol misuse in 
people with ﬁ  rst episode psychosis aged under 36 years 
was high (Hambrecht and Hafner 1996; Barnes et al 2006; 
Barnett et al 2007). Over half of our sample were misus-
ing drugs at presentation, and over a third had an alcohol 
problem. Although it is difﬁ  cult to compare our rates with 
those of previous studies, due to differences in samples and 
methodologies, it seems the rates for drug and alcohol misuse 
in our study are a little higher than those reported in previous 
UK studies (Duke et al 1994; Menezes et al 1996; Cantwell 
et al 1999; McCreadie et al 2002). It has been argued that 
the prevalence of drug misuse is higher in inner-cities, par-
ticularly inner-city London, than in suburban or rural areas 
(Weaver et al 2003; Barnes et al 2006). The current study 
was carried out in Northumberland, a county consisting of 
urban and rural areas. It is the least densely populated county 
in England, but over half of the population live in less than 
5% of the total land area (see www.northumberland.gov.uk). 
It could be that patterns of drug and alcohol misuse differ 
between urban and rural environments, but not necessarily 
that there is less substance misuse in rural parts of the UK. In 
the US, Mueser and colleagues (2001) compared substance 
misuse in schizophrenia in a rural and an urban area and 
found the rural area had higher rates of alcohol and cannabis 
misuse, and lower rates of cocaine misuse. Weaver and col-
leagues (2003) reported substance misuse in patients with 
psychotic illnesses in a suburban area to be about as high as 
that for similar patients in inner-city London.
The present study supports previous research that has 
found a higher proportion of young male patients among 
substance misusers (Cantwell et al 1999; Barnes et al 2006). 
Age differences between the groups were not signiﬁ  cant, 
although this will have been inﬂ  uenced by the fact that only 
patients under 36 years were included in this study.
Hospital admission days
A number of studies have found an association between 
increased hospital days and drug and alcohol misuse in 
Table 2 Risk assessment and hospital admissions
All diagnoses  Total  Drugs  Alcohol  Both drugs   No sub
       and  alcohol  misuse
Total number of patients 251  77  25  63  86
Violence towards others and property
Violence to others  63 (25%)  22 (29%)  5 (20%)  29 (46%)  7 (8%)
Violence to property  47 (19%)  19 (25%)  2 (8%)  22 (35%)  4 (5%)
Hospital admissions
Number admitted  155  51  9  45  50
Number of days  30043  16171  896  4786  8190
Mean days (SD)  120  210 (393)  36 (87)  76 (171)  95 (193)Neuropsychiatric Disease and Treatment 2008:4(2) 421
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patients with psychosis (Drake et al 1989; Menezes et al 
1996; Swofford 1996), and others have found no association 
(Duke et al 2001; Cantwell 2003). We found that patients 
who misused drugs spent more days in hospital than those 
who misused both drugs and alcohol, and those who misused 
alcohol. Drug misuse was associated with more hospital days 
but alcohol misuse was not. No signiﬁ  cant difference was 
found between patients who misused alcohol and those who 
did not misuse any substances. To our knowledge, no other 
studies have examined drug and alcohol misuse separately, 
and most have combined drug and alcohol misuse and studied 
substance misuse (Cantwell et al 2003).
Modestin and colleagues (2001) who studied dual diag-
nosis in schizophrenic patients concluded that patients who 
misused illegal drugs had poorer outcomes than those who 
misused alcohol and those who did not misuse substances. 
Duke and colleagues (1994) found that patients who mis-
used alcohol had a shorter length of illness than those who 
did not. They suggested the possibility that alcohol may 
protect patients from presenting in the early stages possibly 
by alleviating the distress associated with acute illness. 
They also suggested that alcohol may have masked the 
early stages of a psychotic illness so that later age at onset 
and shorter length of illness were recorded in their study. 
Duke and colleagues (1994) and Modestin and colleagues 
(2001) found the course of psychotic illness in patients who 
misused alcohol to be similar to that in those who did not 
misuse any substances. Our results support this ﬁ  nding and 
no difference was found with regard to overall hospital days 
between patients who misused alcohol and those who did not 
misuse any substances.
Violence towards people and property
Although patients who misused drugs spent more days in hos-
pital than all other groups, those who misused both drugs and 
alcohol were signiﬁ  cantly more likely to have been violent 
towards other people and property. This supports previous 
evidence that patients with schizophrenia who misused alco-
hol were more likely to commit violent offences than those 
who did not misuse alcohol (Swanson et al 1990; Rasanen 
et al 1998). A consistent relationship has been demonstrated 
between alcohol misuse and violent behavior in the general 
population. Swanson (1993) argued that although not all 
alcoholics are violent, they are more likely than nonalcoholics 
to have a history of violent behavior. A number of reasons 
have been suggested to explain the relationship between 
alcohol and violence, including biochemical, psychological, 
cultural, and situational factors. Higher rates of violence and 
aggression among people with mental health disorders have 
repeatedly been shown, particularly when they misused drugs 
(Soyka 2000). A literature search did not reveal any studies 
that compared the effects of drugs and alcohol separately 
on violence in people with psychosis. Further research with 
larger samples is needed to understand the complex relation-
ship between psychosis, drugs, alcohol, and violence.
Strengths and weaknesses
A unique strength of this study is that it used 8 years of 
prospective follow-up data, and data were gathered from a 
deﬁ  ned catchment area with a relatively stable population. 
Another strength is that very few cases of ﬁ  rst-episode psy-
chosis were missed. Data were collected on patients under 
36 who were seen by the Northumberland EIP team or were 
referred to the PACE team by Consultant Psychiatrists. Data 
on all people who had a hospital admission were collected and 
this was checked through the Trust’s computerized patient 
information system.
The fact that all ﬁ  rst-episode psychosis diagnoses were 
included meant that the present study was more representative 
of all cases of ﬁ  rst-episode psychosis in people aged under 36 
years who would be referred to an EIP team, as diagnoses of 
substance-induced psychoses and affective psychoses were 
included. Most UK studies have focused on schizophrenia 
and schizophrenia-spectrum disorders and have excluded 
other psychotic diagnoses (Duke et al 2001; McCreadie 
2002; Cantwell 2003; Barnes et al 2006; ). Furthermore, the 
present study included inpatients and outpatients who had 
accessed secondary mental health services for treatment for 
a ﬁ  rst-episode of psychosis. Therefore, data were also col-
lected for patients who had not been admitted to hospital. 
Many previous studies of substance misuse in ﬁ  rst-episode 
psychosis have been deﬁ  ned by ﬁ  rst admission (Hambrect 
and Hafner 1996; Barnes et al 2006). It is arguable that these 
fail to reﬂ  ect accurately the rates of comorbidity by exclud-
ing those who have not been admitted to hospital. In patients 
with psychosis, those receiving in-patient care have been 
shown to have higher rates of comorbidity of drug misuse 
(Mueser et al 1990). The observational design used in the 
present study is more likely to reﬂ  ect the true prevalence and 
course of substance misuse among people with ﬁ  rst-episode 
psychosis.
The PACE methodology does have limitations. There was 
no detailed information about the frequency and amounts of 
drugs taken, nor the degree of dependence. However, even 
relatively low levels of comorbid substance misuse appear to 
be associated with poor outcomes in schizophrenia, including Neuropsychiatric Disease and Treatment 2008:4(2) 422
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a greater risk of relapse and poorer response to conventional 
antipsychotics (Kavanagh et al 2004; Barnes et al 2006). 
Inclusion in the alcohol misuse category was more strin-
gent than for drug misuse as patients were only included if 
clinicians had reported that they had an alcohol problem, 
whereas any use of illicit drugs led to inclusion in the drug 
misuse category. A common problem, which we share with 
other studies, is the possible unreliability of self-reports of 
drug and alcohol misuse. However, a number of studies 
have recently found patients’ self-reported drug misuse to 
be accurate and to correlate highly with urine drug-screening 
(Hides et al 2006).
Some confounding variables that we did not measure or 
control for may have inﬂ  uenced the results of this study, such 
as socio-economic or employment factors. Variables such 
as male gender, young age, substance misuse, and violence 
which have been closely linked in previous studies (Soyka 
2000) may have confounded some ﬁ  ndings.
A further limitation was the small sample sizes, particu-
larly for the alcohol misuse group (n = 25). This study needs 
to be replicated with a larger sample before conclusions about 
the effects of alcohol, either on its own or in combination 
with drugs, can be made.
Implications for the future
In ﬁ  rst episode psychosis, a co-existing alcohol problem 
does not appear to lead to poorer outcomes, as measured by 
hospital days. Many EIP teams are currently advising patients 
that using “skunk” cannabis, amphetamine, and cocaine 
may be more harmful to them than alcohol. Although this 
strategy is controversial, this report provides some support 
for it. Further research and replication of these ﬁ  ndings are 
needed. A future study should include a larger sample size 
and the collection of potential confounding variables, such 
as socio-economic and employment factors, which would 
allow an analysis of covariates.
Our ﬁ  ndings support Barnett and colleagues (2007) who 
recommended that close cooperation is needed between EIP 
teams and substance misuse services. These ﬁ  ndings have 
implications for staff training. EIP teams should be aware 
of the higher risk of violence towards others associated with 
a combination of alcohol and drugs, and drug and alcohol 
intake reduction strategies should be a priority.
Conclusions
High rates of drug and alcohol misuse in young people 
with first-episode psychosis highlight the need for the 
development of effective therapeutic interventions which 
address drug and alcohol misuse and violent behavior in this 
high-risk group. Drug and alcohol histories should be prop-
erly detailed by clinicians to help further case-note analyses, 
and to enable further research.
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